Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07160023

Local Registry of Primary Cutaneous T-cell Lymphomas

This registry aims to collect retrospective and prospective data on patients with primary cutaneous T-cell lymphoma who are treated at the Dermatology Clinic of the IRCCS Policlinico San Matteo Foundation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

6 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

SC Dermatologia, Fondazione IRCCS Policlinico San Matteo

Pavia, 27100, Italy

Location status: Recruiting

Location contact

Valeria Brazzelli, MD

CONTACT

[email protected]

0382503794

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primary cutaneous T-cell lymphoma attending the outpatient clinics of the Dermatology Unit in Pavia

Treatment and study plan

Primary outcomes

  1. prevalence of cutaneous T-cell lymphoma (CTCL) variants

    Time frame: October 2033

    The prevalence and the exact binomial 95% CI will be presented.

Secondary outcomes

  1. survival among the various subtypes of CTCL

    Time frame: October 2033

    To compare survival among the various subtypes of CTCL, the survival rate will be reported as deaths per 100 person-years; the start date of follow-up will be the diagnosis of the disease. The groups will be compared using the log-rank test and survival will be described using Kaplan-Meier curves.

  2. Association between clinical, histopathological and immunophenotypic characteristics of patients with cutaneous T-cell lymphoma and overall survival

    Time frame: October 2033

    A Cox model will be used to derive the hazard ratio (HR) and relative 95% CI. Harrell's c statistic will be calculated for the model's ability to discriminate. Estimates will be adjusted as far as possible for potential confounding factors.

  3. dermatoscopic features of cutaneous T-cell lymphomas

    Time frame: October 2033

    Descriptive statistics will be calculated for each type of cutaneous lymphoma.

Study contacts

Contact information is provided by the study sponsor or research team.

Valeria Brazzelli, MD

CONTACT

[email protected]

0382503794

Sponsors and collaborators

Lead sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Other

Registry information

Acronym: CuTLy

Important dates

Study start
2023
Primary completion
2033
Study completion
2033
First posted
Sep 8, 2025
Registry last updated
Sep 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.